Human Cell Design scientists are proud to present at the 59th EASD two new and innovative human T1D & T2D cell models
Hamburg, October 2-6, 2023 

This year many EASD talks demonstrated the relevance of Endoc-βH5® human beta cells as the one of Arnaud Dance from the Dr. Anne Bonnefond group. In parallel, Human Cell design scientists are proud to present latest results obtained on the development of Endoc-βH5® based T1D & T2D disease human beta cell models and associated assays for opening new avenues in the Diabetes research.

HLA-A2 Endoc-βH5®

A highly functional human pancreatic beta cell that can model autoimmune Type I Diabetes T cell-mediated beta cell killing. Discover more about our new autoimmune Type I Diabetes human model, HLA-A2-EndoC-βH5® cells:

Endoc-βH5® based assay of inflammation

A highly functional human pancreatic beta cells that can model inflammatory responses. Discover more about our new Cytokine-mediated human beta cell inflammation assay using EndoC-βH5® cells:

GLTx Endoc-βH5®

A highly functional pancreatic beta cells that can model glucolipotoxicity repsonse. Discover more about our new Glucolipotoxicity mediated Type 2 Diabetes model, GLTx Endoc-βH5® cells:

Contact us for any further information you might need at: contact@humancelldesign.com

Hope to have the opportunity to meet you!